Clinical Trial

Host-Microbe Interactions in Biliary Dilatation

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 9, 2025 (before its estimated June 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study is an observational cohort study aimed at continuously enrolling patients with biliary dilatation and healthy controls. It will collect bile duct tissue samples and clinical data from participants across all age groups to establish a comprehensive cohort for biliary dilatation research. Based on this cohort, the study seeks to investigate the molecular mechanisms underlying biliary dilatation development and progression, explore the role of host-microbiome interactions in disease processes, and identify biomarkers associated with complications and malignancy risk, to establish evidence-based strategies for improved diagnosis and treatment of biliary dilatation.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-08-26.
Trial Details
NCT Number NCT07152496
Lead Sponsor Beijing Tsinghua Chang Gung Hospital
Conditions Choledochal Cyst
Enrollment 400 participants
Start Date 2025-12-15
Primary Completion 2026-06-01 (estimated)
Study Completion 2026-07-01 (estimated)
Updated on ClinicalTrials.gov 2025-12-09